Green Tea and Bilberry Protective Effect against Gentamicin-Induced Nephrotoxicity in Rats

被引:2
作者
Veljkovic, Milica [1 ]
Pavlovic, Dragana R. [2 ]
Ilic, Ivan [3 ]
Sokolovic, Dusan [4 ]
机构
[1] Univ Nis, Fac Med, Dept Physiol, Nish, Serbia
[2] Univ Nis, Fac Med, Dept Pharm, Nish, Serbia
[3] Univ Nis, Fac Med, Dept Pathol, Nish, Serbia
[4] Univ Nis, Fac Med, Dept Biochem, Nish, Serbia
关键词
gentamicin; nephrotoxicity; green tea; bilberry; rat;
D O I
10.5937/afmnai2003261V
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of our study was to investigate if green tea and bilberry have protective effect on gentamicin-induced kidney damage, when applied together, and to make a connection between their effects. GM group of rats received only gentamicin, GT group received green tea only, B group received only bilberry, whereas control (C) group received saline only. GT+GM group received green tea together with gentamicin, and B+GM group received bilberry together with gentamicin. Biochemical analysis showed significantly increased urea and creatinine levels in GM group when compared to groups that also received bilberry or green tea. Histological analysis showed complete disruption of glomerular basal membrane as well as basal membranes of both proximal and distal tubules in GM group. These destructive effects were significantly milder and limited only to proximal tubules when bilberry or green tea was applied simultaneously with gentamicin. Both green tea and bilberry protective effect on gentamicin-induced nephrotoxicity is manifested because of their strong antioxidant activity. Since they are strong antioxidants, widely distributed in nature, they can offer available and inexpensive adjuvant therapy in Gram-negative infections, which can relieve gentamicin nephrotoxicity, but will not affect its bactericidal effect.
引用
收藏
页码:261 / 266
页数:6
相关论文
共 9 条
[1]  
Acharya CR., 2013, NATL J PHYSL PHARM P, V3, P14, DOI [DOI 10.5455/NJPPP.2013.3.14-20, 10.5455/njppp.2013.3.14-20]
[2]   EARLY EFFECTS OF GENTAMICIN, TOBRAMYCIN, AND AMIKACIN ON THE HUMAN-KIDNEY [J].
DEBROE, ME ;
PAULUS, GJ ;
VERPOOTEN, GA ;
ROELS, F ;
BUYSSENS, N ;
WEDEEN, R ;
VANHOOF, F ;
TULKENS, PM .
KIDNEY INTERNATIONAL, 1984, 25 (04) :643-652
[3]   Light-Microscopic Immunocytochemistry for Gentamicin and Its Use for Studying Uptake of the Drug in Kidney [J].
Fujiwara, Kunio ;
Shin, Masashi ;
Matsunaga, Hayato ;
Saita, Tetsuya ;
Larsson, Lars-Inge .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (08) :3302-3307
[4]   Protective effect of green tea extract on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney [J].
Khan, Sara A. ;
Priyamvada, Shubha ;
Farooq, Neelam ;
Khan, Sheeba ;
Khan, Md Wasim ;
Yusufi, Ahad N. K. .
PHARMACOLOGICAL RESEARCH, 2009, 59 (04) :254-262
[5]   TUBULAR INJURY AND REGENERATION IN THE RAT-KIDNEY FOLLOWING ACUTE EXPOSURE TO GENTAMICIN - A TIME-COURSE STUDY [J].
NONCLERCQ, D ;
WRONA, S ;
TOUBEAU, G ;
ZANEN, J ;
HEUSONSTIENNON, JA ;
SCHAUDIES, RP ;
LAURENT, G .
RENAL FAILURE, 1992, 14 (04) :507-521
[6]   GENTAMICIN NEPHROTOXICITY IN ANIMALS: CURRENT KNOWLEDGE AND FUTURE PERSPECTIVES [J].
Randjelovic, Pavle ;
Veljkovic, Slavimir ;
Stojiljkovic, Nenad ;
Sokolovic, Dusan ;
Ilic, Ivan .
EXCLI JOURNAL, 2017, 16 :388-399
[7]   Bilberry: Chemical Profiling, in Vitro and in Vivo Antioxidant Activity and Nephroprotective Effect against Gentamicin Toxicity in Rats [J].
Veljkovic, Milica ;
Pavlovic, Dragana R. ;
Stojiljkovic, Nenad ;
Ilic, Sonja ;
Jovanovic, Ivan ;
Ulrih, Natasa Poklar ;
Rakic, Violeta ;
Velickovic, Ljubinka ;
Sokolovic, Dusan .
PHYTOTHERAPY RESEARCH, 2017, 31 (01) :115-123
[8]   Morphological and morphometric study of protective effect of green tea in gentamicin-induced nephrotoxicity in rats [J].
Veljkovic, Milica ;
Pavlovic, Dragana R. ;
Stojiljkovic, Nenad ;
Ilic, Sonja ;
Petrovic, Aleksandar ;
Jovanovic, Ivan ;
Radenkovic, Mirjana .
LIFE SCIENCES, 2016, 147 :85-91
[9]   ONCE-DAILY DOSING DECREASES RENAL ACCUMULATION OF GENTAMICIN AND NETILMICIN [J].
VERPOOTEN, GA ;
GIULIANO, RA ;
VERBIST, L ;
EESTERMANS, G ;
DEBROE, ME .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (01) :22-27